Annals of Oncology

From WikiMD's WELLNESSPEDIA

Annals of Oncology[edit]

Annals of Oncology is a peer-reviewed medical journal specializing in oncology, published by Oxford University Press. It serves as the official journal of the European Society for Medical Oncology (ESMO). The current editor-in-chief is Professor Fabrice André, based in Villejuif, France.

Some articles are available for free public access.

Before coming to Oxford University Press, the journal was published by Springer Science+Business Media

Overview[edit]

The Annals of Oncology was established to disseminate significant clinical and translational research in oncology, with an emphasis on innovative studies contributing to the understanding and treatment of cancer. The journal aims to provide a platform for oncologists and researchers to share findings that have the potential to impact cancer care globally.

Publication Details[edit]

Impact[edit]

The journal is renowned for its high impact factor, making it one of the leading publications in the field of oncology. It is instrumental in advancing the scientific foundation of oncology through rigorous peer-review and a commitment to high standards in research publication.

Editorial Board[edit]

The editorial board, led by Professor Fabrice André, comprises a diverse group of leading oncologists and researchers from around the world. This board ensures the journal maintains its high standard by overseeing the peer review process and selecting only the most groundbreaking and relevant research for publication.

Topics Covered[edit]

The Annals of Oncology covers a wide range of topics within the field of oncology, including:

  • Clinical trials
  • Molecular biology
  • Biomarkers
  • Targeted therapies
  • Palliative care

External Links[edit]

Stub icon 1 Stub icon 2

This article about an oncology journal is a stub. You can help WikiMD by expanding the page.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

WikiMD logo

This article is a stub

You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories.

Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Annals_of_Oncology&oldid=6532266"